title: Haemorrhagic shock due to spontaneous splenic rupture in a patient subsequently diagnosed with advanced ovarian cancer.
authors.affiliation: a Gynaecological Oncology Department , Royal London Hospital , Barts Health NHS Trust , London , United Kingdom.
authors.forename: Mariaclelia
authors.initials: M
authors.lastname: La Russa
authors.affiliation: a Gynaecological Oncology Department , Royal London Hospital , Barts Health NHS Trust , London , United Kingdom.
authors.forename: Fani
authors.initials: F
authors.lastname: Kokka
authors.affiliation: b Medical Oncology Department , St Bartholomew's Hospital , Barts Health NHS Trust , London , United Kingdom.
authors.forename: Michelle
authors.initials: M
authors.lastname: Lockley
authors.affiliation: a Gynaecological Oncology Department , Royal London Hospital , Barts Health NHS Trust , London , United Kingdom.
authors.forename: Elly
authors.initials: E
authors.lastname: Brockbank
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D020360:Neoadjuvant Therapy; D010051:Ovarian Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D012422:Rupture, Spontaneous; D000074868:Salpingo-oophorectomy; D012771:Shock, Hemorrhagic / Q000209:etiology*; D013161:Splenic Rupture / Q000150:complications*; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D014859:Warfarin